Source: Marine Drugs. Conference titles: International Symposium on Marine Natural Products. Unidade: ICB
Subjects: METABÓLITOS SECUNDÁRIOS, PRODUTOS NATURAIS, EXPRESSÃO GÊNICA, REGULAÇÃO GÊNICA, MELANOMA, CÉLULAS CULTIVADAS DE TUMOR
ABNT
HIRATA, Amanda S. et al. Seriniquinone, metabolite from a marine bacterium, and its synthetic derivative for melanoma and resistant melanoma cells treatment. Marine Drugs. Basel: MDPI AG. Disponível em: https://doi.org/10.3390/md18010040. Acesso em: 29 jun. 2024. , 2020APA
Hirata, A. S., Branco, P. C., Rezende-Teixeira, P., Jimenez, P. C., Clair, J. J. L., Fenical, W., & Lotufo, L. V. C. (2020). Seriniquinone, metabolite from a marine bacterium, and its synthetic derivative for melanoma and resistant melanoma cells treatment. Marine Drugs. Basel: MDPI AG. doi:10.3390/md18010040NLM
Hirata AS, Branco PC, Rezende-Teixeira P, Jimenez PC, Clair JJL, Fenical W, Lotufo LVC. Seriniquinone, metabolite from a marine bacterium, and its synthetic derivative for melanoma and resistant melanoma cells treatment [Internet]. Marine Drugs. 2020 ; 18( 1): 114.[citado 2024 jun. 29 ] Available from: https://doi.org/10.3390/md18010040Vancouver
Hirata AS, Branco PC, Rezende-Teixeira P, Jimenez PC, Clair JJL, Fenical W, Lotufo LVC. Seriniquinone, metabolite from a marine bacterium, and its synthetic derivative for melanoma and resistant melanoma cells treatment [Internet]. Marine Drugs. 2020 ; 18( 1): 114.[citado 2024 jun. 29 ] Available from: https://doi.org/10.3390/md18010040